Rockefeller Capital Management
CHRS icon

Rockefeller Capital Management’s Coherus Oncology CHRS Stock Holding History

Rockefeller Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$548 Hold
324
– – ﹤0.01% 4553
2025
Q4 		$460 Hold
324
– – ﹤0.01% 4537
2025
Q3 		$531 Buy
+324
New +$360 ﹤0.01% 4266
2023
Q1 		– Sell
-449
Closed -$3K – 2299
2022
Q4 		$3K Hold
449
– – ﹤0.01% 3442
2022
Q3 		$4K Sell
449
-106
-19% -$1.07K ﹤0.01% 3384
2022
Q2 		$4K Buy
555
+231
+71% +$2.01K ﹤0.01% 3513
2022
Q1 		$4K Sell
324
-11
-3% -$140 ﹤0.01% 3392
2021
Q4 		$5K Sell
335
-106
-24% -$1.85K ﹤0.01% 3247
2021
Q3 		$7K Hold
441
– – ﹤0.01% 3030
2021
Q2 		$6K Hold
441
– – ﹤0.01% 2959
2021
Q1 		$6K Buy
+441
New +$7.49K ﹤0.01% 2822
2020
Q1 		– Sell
-4
Closed – – 2368
2019
Q4 		$0 Buy
+4
New +$74 ﹤0.01% 2066

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return